PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression.

Autor: Chang, Yu-Chan1 (AUTHOR) yuchanchang@nycu.edu.tw, Chan, Ming-Hsien1 (AUTHOR), Li, Chien-Hsiu2 (AUTHOR), Chen, Chi-Long3,4 (AUTHOR), Tsai, Wen-Chiuan5 (AUTHOR), Hsiao, Michael6 (AUTHOR)
Zdroj: Cell Communication & Signaling. 5/13/2024, Vol. 22 Issue 1, p1-19. 19p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje